Gen-Probe To Launch Aptima HPV Test By Nov. 11
This article was originally published in The Gray Sheet
You may also be interested in...
Agency’s Nov. 28 final guidance discusses clinical trial requirements for human papillomavirus tests.
The U.S. Preventive Services Task Force finds the evidence inconclusive for employing human papillomavirus testing as part of cervical cancer screening for women over 30, and it explicitly recommends against HPV testing in younger women.
Benefits, risks higher for mesh prolapse repair